Back
Veolia Environnement SA Vs. Kymera Therapeutics, Inc. Industry Stock Comparison
Sell
43
VEOEY
Veolia Environnement SA
Last Price:
$16.86
Seasonality Move:
6.6%
Buy
87
KYMR
Kymera Therapeutics, Inc.
Last Price:
$89.98
Seasonality Move:
7.7%
Sell
43
Veolia Environnement SA (VEOEY)
is a Sell
Is Veolia Environnement SA a Buy, Sell or Hold?
-
The current Veolia Environnement SA [VEOEY] share price is $16.93. The Score for VEOEY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
VEOEY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
87
Kymera Therapeutics, Inc. (KYMR)
is a Buy
Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Kymera Therapeutics, Inc. [KYMR] share price is $86.88. The Score for KYMR is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
VEOEY Stock Price Chart
What is Veolia Environnement SA's stock price today?
-
The Veolia Environnement SA share price today is $16.93Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VEOEY is experiencing selling pressure, which indicates risk of future bearish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics, Inc.'s stock price today?
-
The Kymera Therapeutics, Inc. share price today is $86.88Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.
VEOEY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 51.37 | Buy |
| Chaikin Money Flow: | -51552 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.53 - 17.07) | Buy |
| Bollinger Bands (100): | (16.6 - 17.5) | Sell |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.97 | Buy |
| Relative Strength Index (14 RSI): | 72.81 | Buy |
| Chaikin Money Flow: | -897315 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (58.72 - 73.96) | Buy |
| Bollinger Bands (100): | (43.27 - 64.19) | Buy |
VEOEY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.03 | Sell |
| 20-day SMA: | 16.83 | Buy |
| 50-day SMA: | 16.88 | Buy |
| 200-day SMA: | 17.14 | Sell |
| 8-day EMA: | 16.97 | Sell |
| 20-day EMA: | 16.89 | Buy |
| 50-day EMA: | 16.9 | Buy |
| 200-day EMA: | 16.81 | Buy |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 72.38 | Buy |
| 20-day SMA: | 67.89 | Buy |
| 50-day SMA: | 62.54 | Buy |
| 200-day SMA: | 44.51 | Buy |
| 8-day EMA: | 75.59 | Buy |
| 20-day EMA: | 69.41 | Buy |
| 50-day EMA: | 62.91 | Buy |
| 200-day EMA: | 49.79 | Buy |
Veolia Environnement SA Earnings Growth & VEOEY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.39 per share, and an increase next year of $0.14 per share.
Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.36 per share.
Veolia Environnement SA Technical Analysis
| Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics, Inc. Technical Analysis
| Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||